Whole-Brain Myelin Imaging Using 3D Double-Echo Sliding Inversion Recovery Ultrashort Echo Time (DESIRE UTE) MRI

Ya-Jun Ma1, Adam C Searleman1, Hyungseok Jang1

  • 1From the Departments of Radiology (Y.J.M., A.C.S., H.J., J.W., E.Y.C., G.M.B., J.D.) and Neurosciences (J.C.), University of California San Diego, 9452 Medical Center Dr, La Jolla, CA 92037; and Radiology Service, VA San Diego Healthcare System, San Diego, Calif (J.W., E.Y.C.).

Radiology
|November 21, 2019
PubMed

Insights

This study introduces a new MRI technique for direct myelin imaging, successfully visualizing myelin in the brain and detecting reduced signal in multiple sclerosis lesions.

Area of Science:

  • Biomedical Imaging
  • Neuroimaging
  • Magnetic Resonance Imaging

Background:

  • Direct myelin imaging is challenging due to long T2 water signal contamination.
  • Inversion recovery (IR) pulses can null unwanted long T2 signals.
  • Ultrashort echo time (UTE) sequences detect the remaining ultrashort T2 signal from myelin.

Purpose of the Study:

  • To develop a patient-specific, whole-brain myelin imaging method.
  • Utilize a three-dimensional double-echo sliding inversion recovery (DESIRE) UTE sequence.
  • Enable direct visualization of myelin.

Main Methods:

  • The DESIRE UTE sequence acquires multiple IR images with varying inversion times in one scan.
  • Optimal inversion time is determined by minimal signal on the second echo.
  • Myelin images are created by subtracting the second echo from the first UTE image.

Main Results:

  • High signal intensity and specific T2*/T1 values confirmed ultrashort-T2 myelin proton imaging.
  • DESIRE UTE selectively suppressed gadobenate dimeglumine phantoms.
  • Ex vivo MS lesions showed signal loss consistent with histology.
  • Human study revealed significantly lower normalized signal in MS lesions (0.19 ± 0.10) vs. normal-appearing white matter (0.76 ± 0.11, P < .001).

Conclusions:

  • The DESIRE UTE sequence enables whole-brain myelin imaging.
  • This technique is compatible with clinical 3-T scanners.
  • Provides a method for direct myelin quantification and assessment in neurological conditions.